Can we identify response markers to antihypertensive drugs? First results from the Ideal Trial

Autor: F., Gueyffier, F., Subtil, T., Bejan-Angoulvant, Zerbib, Yves, Jp, Baguet, Jm, Boivin, A., Mercier, G., Leftheriotis, Jp, Gagnol, Jp, Fauvel, C., Giraud, G., Bricca, D., Maucort-Boulch, S, Erpeldinger

Publikováno v: Journal of Human Hypertension
Journal of Human Hypertension, Nature Publishing Group, 2014, pp.doi: 10.1038/jhh.2014.29
Journal of Human Hypertension, 2014, pp.doi: 10.1038/jhh.2014.29

International audience; Current antihypertensive strategies do not take into account that individual characteristics may influence the magnitude of blood pressure (BP) reduction. Guidelines promote trial-and-error approaches with many different drugs

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::b9b8e36a7ba38d104fb3a274df09246b
https://hal.archives-ouvertes.fr/hal-01005386

2024 European Society of Hypertension clinical practice guidelines for the management of arterial hypertension.

Autor: Kreutz R; Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Clinical Pharmacology and Toxicology, Berlin, Germany. Electronic address: reinhold.kreutz@charite.de., Brunström M; Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden., Burnier M; Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland., Grassi G; Clinica Medica, University Milano-Bicocca, Milan, Italy., Januszewicz A; Department of Hypertension, National Institute of Cardiology, Warsaw, Poland., Muiesan ML; UOC 2 Medicina, ASST Spedali Civili di Brescia, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy., Tsioufis K; First Department of Cardiology, Medical School, University of Athens, Hippokration Hospital, Athens, Greece., de Pinho RM; General and Family Doctor, ULS Entre Douro e Vouga, São João da Madeira, Portugal., Albini FL; Centro Ipertensione e Protezione Cardiovascolare, Milano-Nord, Italy; ATS-Milano Città Metropolitana, Milan, Italy., Boivin JM; Department of Family Medicine, Lorraine University, Nancy, France; ESH Hypertension Excellence Center Coordinator, Nancy, France., Doumas M; 2nd Prop Department of Internal Medicine, Aristotle University, Thessaloniki, Greece., Nemcsik J; Department of Family Medicine, Semmelweis University, Budapest, Hungary., Rodilla E; Hypertension Unit, Hospital de Sagunto, Universidad Cardenal Herrera-CEU, CEU Universities, Valencia, Spain., Agabiti-Rosei E; Department of Clinical and Experimental Sciences, University of Brescia, Italy., Algharably EAE; Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Clinical Pharmacology and Toxicology, Berlin, Germany., Agnelli G; Istituti Clinici Scientifici Maugeri, IRCCS, University of Perugia, Perugia, Italy., Benetos A; Department of Geriatric Medicine and INSERM DCAC, CHRU-Nancy, Université de Lorraine, Nancy, France., Hitij JB; Department of Hypertension, University Medical Centre Ljubljana, Medical University Ljubljana, Ljubljana, Slovenia., Cífková R; Center for Cardiovascular Prevention, Charles University in Prague, First Faculty of Medicine and Thomayer University Hospital, Prague, Czech Republic; Department of Medicine II, Charles University in Prague, First Faculty of Medicine, Prague, Czech Republic., Cornelissen V; Department of Rehabilitation Sciences, KU Leuven, Leuven, Belgium., Danser AHJ; Division of Pharmacology and Vascular Medicine, Department of Internal Medicine, Erasmus MC, University Medical Center Rotterdam, the Netherlands., Delles C; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK., Huelgas RG; Clinical Management Unit of Internal Medicine, Hospital Regional Universitario de Málaga, Instituto de Investigación Biomédica de Málaga, University of Málaga, Málaga, Spain; CIBER Fisiopatología de la Obesidad y la Nutrición, Instituto de Salud Carlos III, Madrid, Spain., Járai Z; South-Buda Center Hospital St. Imre University Hospital, Budapest & Semmelweis University, Budapest, Hungary., Palatini P; Studium Patavinum, Department of Medicine, University of Padova, Padova, Italy., Pathak A; Princess Grace Hospital Monaco (Centre Hospitalier Princesse Grace, CHPG), Monaco., Persu A; Division of Cardiology, Department of Cardiovascular Diseases, Cliniques Universitaires Saint-Luc and Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium., Polonia J; Faculty of Medicine of Porto, CINTESIS, Portugal., Sarafidis P; 1st Department of Nephrology, Hippokration Hospital, Aristotle University of Thessaloniki, Greece., Stergiou G; Hypertension Center STRIDE-7, School of Medicine, Third Department of Medicine, Sotiria Hospital, National and Kapodistrian University of Athens, Athens, Greece., Thomopoulos C; Department of Cardiology, General Hospital of Athens 'Laiko', Greece., Wanner C; Division of Nephrology, Wuerzburg University Clinic, Wuerzburg, Germany., Weber T; Cardiology Department, Klinikum Wels-Grieskirchen, Wels, Austria., Williams B; Institute of Cardiovascular Sciences, University College London (UCL), National Institute for Health Research UCL Hospitals Biomedical Research Centre, London, UK., Kjeldsen SE; Departments of Cardiology and Nephrology, Institute for Clinical Medicine, and Ullevål Hospital, University of Oslo, Oslo, Norway., Mancia G; University of Milano-Bicocca, Milan, Italy.

Publikováno v: European journal of internal medicine [Eur J Intern Med] 2024 Aug; Vol. 126, pp. 1-15. Date of Electronic Publication: 2024 Jun 24.

Parental acceptability of vaccinating young children against influenza and COVID-19.

Autor: Berthélémy C; Lorraine University, France., Bouché P; Lorraine University, France., Lamiral Z; Inserm, Centre d'Investigations Cliniques Plurithématique 1433, France., Boivin JM; Lorraine University, France; Inserm, Centre d'Investigations Cliniques Plurithématique 1433, France. Electronic address: jm.boivin@chru-nancy.fr.

Publikováno v: Vaccine [Vaccine] 2023 Sep 07; Vol. 41 (39), pp. 5791-5796. Date of Electronic Publication: 2023 Aug 12.

Birth weight and subclinical cardiovascular and renal damage in a population-based study (the STANISLAS cohort study).

Autor: Lopez-Sublet M; AP-HP, Hôpital Avicenne, Centre d'Excellence Européen en Hypertension Artérielle, Service de Médecine Interne.; INSERM UMR 942 MASCOT, Paris 13-Université Paris Nord, Bobigny.; FCRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists)., Merkling T; FCRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists).; Université de Lorraine, INSERM CIC-P 1433, CHRU de Nancy, INSERM U1116, Nancy., Girerd N; FCRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists).; Université de Lorraine, INSERM CIC-P 1433, CHRU de Nancy, INSERM U1116, Nancy., Xhaard C; FCRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists).; Université de Lorraine, INSERM CIC-P 1433, CHRU de Nancy, INSERM U1116, Nancy., Flahault A; FCRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists).; Service de Néphrologie, Hôpital Européen Georges Pompidou, Paris, France., Bozec E; FCRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists).; Université de Lorraine, INSERM CIC-P 1433, CHRU de Nancy, INSERM U1116, Nancy., Leroy C; FCRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists).; Université de Lorraine, INSERM CIC-P 1433, CHRU de Nancy, INSERM U1116, Nancy., Fujikawa T; FCRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists).; Université de Lorraine, INSERM CIC-P 1433, CHRU de Nancy, INSERM U1116, Nancy., Vaag AA; Steno Diabetes Center Copenhagen, Borgmester Ib Juuls Vej 83, 2730 Herlev, Denmark., Mebazaa A; FCRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists).; UMR-S 942 INSERM, Lariboisière Hospital, Paris.; Paris Diderot University, Sorbonne Paris Cité.; Department of Anaesthesiology and Critical Care, Laribosière Hospital, AP-HP, Paris., Kistorp CM; Department of Endocrinology, Copenhagen University Hospital, Rigshospitalet; Faculty of Health and Medical Sciences, University of Copenhagen, Denmark., Heude B; Université de Paris, Research Center in Epidemiology and Biostatistics (CRESS), INSERM, INRAE, Paris, France., Boivin JM; FCRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists).; Université de Lorraine, INSERM CIC-P 1433, CHRU de Nancy, INSERM U1116, Nancy., Zannad F; FCRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists).; Université de Lorraine, INSERM CIC-P 1433, CHRU de Nancy, INSERM U1116, Nancy., Wagner S; FCRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists).; Université de Lorraine, INSERM CIC-P 1433, CHRU de Nancy, INSERM U1116, Nancy., Rossignol P; FCRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists).; Université de Lorraine, INSERM CIC-P 1433, CHRU de Nancy, INSERM U1116, Nancy.; Medicine and Nephrology-Hemodialysis departments, Princess Grace Hospital, and Monaco Private Hemodialysis Centre, Monaco, Monaco.

Publikováno v: Journal of hypertension [J Hypertens] 2023 Jun 01; Vol. 41 (6), pp. 1040-1050. Date of Electronic Publication: 2023 Apr 17.

Association between eating behaviour and 13-year cardiovascular damages in the initially healthy STANISLAS cohort.

Autor: Puchkova-Sistac A; INSERM CIC 1433, Nancy CHRU, Inserm U1116, FCRIN, INI-CRCT, University of Lorraine, 4 rue du Morvan, 54500 Vandoeuvre-lès-Nancy, France., de Lauzon-Guillain B; Université Paris Cité, INSERM, INRAE, CRESS, HOPITAL HOTEL DIEU, 1 PLACE DU PARVIS NOTREDAME, 75004 PARIS, France., Girerd N; INSERM CIC 1433, Nancy CHRU, Inserm U1116, FCRIN, INI-CRCT, University of Lorraine, 4 rue du Morvan, 54500 Vandoeuvre-lès-Nancy, France., Boivin JM; INSERM CIC 1433, Nancy CHRU, Inserm U1116, FCRIN, INI-CRCT, University of Lorraine, 4 rue du Morvan, 54500 Vandoeuvre-lès-Nancy, France.; Department of General Medicine, University of Lorraine, 9 avenue de la Forêt de Haye, 54500 Vandoeuvre-lès-Nancy, France., Bozec E; INSERM CIC 1433, Nancy CHRU, Inserm U1116, FCRIN, INI-CRCT, University of Lorraine, 4 rue du Morvan, 54500 Vandoeuvre-lès-Nancy, France., Mercklé L; INSERM CIC 1433, Nancy CHRU, Inserm U1116, FCRIN, INI-CRCT, University of Lorraine, 4 rue du Morvan, 54500 Vandoeuvre-lès-Nancy, France., Nazare JA; Centre de Recherche en Nutrition Humaine Rhône-Alpes, Univ-Lyon, CarMeN Laboratory, INSERM, INRA, INSA Lyon, Université Claude Bernard Lyon 1, Hospices Civils de Lyon, F-CRIN/FORCE Network, 165 chemin du Grand Revoyet, Pierre-Bénite, France., Laville M; Centre de Recherche en Nutrition Humaine Rhône-Alpes, Univ-Lyon, CarMeN Laboratory, INSERM, INRA, INSA Lyon, Université Claude Bernard Lyon 1, Hospices Civils de Lyon, F-CRIN/FORCE Network, 165 chemin du Grand Revoyet, Pierre-Bénite, France., Rossignol P; INSERM CIC 1433, Nancy CHRU, Inserm U1116, FCRIN, INI-CRCT, University of Lorraine, 4 rue du Morvan, 54500 Vandoeuvre-lès-Nancy, France., Wagner S; INSERM CIC 1433, Nancy CHRU, Inserm U1116, FCRIN, INI-CRCT, University of Lorraine, 4 rue du Morvan, 54500 Vandoeuvre-lès-Nancy, France.

Publikováno v: European journal of preventive cardiology [Eur J Prev Cardiol] 2023 Mar 01; Vol. 30 (4), pp. 349-357.